Yasushi Sato

发表

Body mass index and quality of life among outpatients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2013, BMC Psychiatry.

Factor structure of the Liebowitz Social Anxiety Scale in community‐dwelling subjects in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Psychiatry and clinical neurosciences.

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2011, Annals of general psychiatry.

Prevalence of metabolic syndrome among patients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Nakaji, 2010, Schizophrenia Research.

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Tsuchimine, 2015, PloS one.

Effect of Itraconazole on Pharmacokinetics of Paroxetine: The Role of Gut Transporters

N. Yasui-Furukori, T. Niioka, S. Kaneko, 2007, Therapeutic Drug Monitoring.

Effect of age and disease on bone mass in Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Annals of General Psychiatry.

Dietary patterns and schizophrenia: a comparison with healthy controls

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Paroxetine-associated hypereosinophilia may clinically resemble a panic attack.

S. Kaneko, Yasushi Sato, H. Kato, 2012, Clinical neuropharmacology.

Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

No association between bone mass and prolactin levels among patients with schizophrenia

Norio Sugawara, S. Kaneko, M. Saito, 2011, Human psychopharmacology.

Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study.

S. Kaneko, S. Tsuchimine, Yasushi Sato, 2012, Journal of clinical psychopharmacology.

Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects

T. Niioka, S. Kaneko, Y. Inoue, 2006, European Journal of Clinical Pharmacology.

Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder

S. Kaneko, M. Saito, Yasushi Sato, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations

T. Niioka, S. Kaneko, M. Saito, 2008, Drug design, development and therapy.

Different serum concentrations of steady‐state valproic acid in two sustained‐release formulations

T. Niioka, S. Kaneko, M. Saito, 2007, Psychiatry and clinical neurosciences.

Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients

N. Yasui-Furukori, S. Kaneko, M. Saito, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

No association between CYP2D6 polymorphisms and personality trait in Japanese.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2007, British journal of clinical pharmacology.

Attitudes toward placebo-controlled clinical trials among depressed patients in Japan.

Norio Sugawara, S. Tsuchimine, Koji Tsuruga, 2018, Journal of affective disorders.

Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2011, Human psychopharmacology.

Body composition in patients with schizophrenia: Comparison with healthy controls

Norio Sugawara, S. Kaneko, I. Takahashi, 2012, Annals of General Psychiatry.

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Norio Sugawara, Kazutoshi Kubo, Masamichi Ishioka, 2019, Neuropsychiatric disease and treatment.

Relationship between occupational stress and depression among psychiatric nurses in Japan

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2016, Archives of environmental & occupational health.

Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia

Norio Sugawara, S. Kaneko, M. Saito, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effects of Age on Paroxetine Efficacy in Patients With Major Depressive Disorder Who Do Not Exhibit an Early Response to Treatment

Kazuhiko Nakamura, S. Kaneko, S. Tsuchimine, 2015, Clinical neuropharmacology.

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response

S. Kaneko, S. Tsuchimine, A. Kaneda, 2014, Neuropsychiatric disease and treatment.

Clock drawing performance in a community-dwelling population: Normative data for Japanese subjects

Norio Sugawara, S. Nakaji, S. Kaneko, 2010, Aging & mental health.

Dietary patterns are associated with obesity in Japanese patients with schizophrenia

Manabu Saito, Norio Sugawara, N. Yasui-Furukori, 2014, BMC Psychiatry.

Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2009, The Journal of clinical psychiatry.

A crossover study on the glucose metabolism between treatment with olanzapine and risperidone in schizophrenic patients.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2010, Experimental and clinical psychopharmacology.

Ankle brachial pressure index as a marker of apathy in a community‐dwelling population

Norio Sugawara, S. Nakaji, S. Kaneko, 2011, International journal of geriatric psychiatry.

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

Norio Sugawara, K. Oniki, A. Kajiwara, 2013, Neuropsychiatric disease and treatment.

New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone

S. Kaneko, Yasushi Sato, T. Moriyama, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2019, Neuropsychiatric disease and treatment.

Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population

Norio Sugawara, S. Nakaji, S. Kaneko, 2010, BMC psychiatry.

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan

Norio Sugawara, Kazuyo Kitaoka, A. Fujii, 2017, Neuropsychiatric disease and treatment.

Comparing the influences of age and disease on distortion in the clock drawing test in Japanese patients with schizophrenia.

Norio Sugawara, S. Nakaji, S. Kaneko, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2018, Neuropsychiatric disease and treatment.

Items of the Montgomery-Åsberg Depression Rating Scale Associated With Response to Paroxetine Treatment in Patients With Major Depressive Disorder

Kazuhiko Nakamura, S. Kaneko, S. Tsuchimine, 2016, Clinical neuropharmacology.

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2018, Neuropsychiatric disease and treatment.

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Ef ﬁ cacy Of Psychoeducation Neuropsychiatric

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2019 .

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Ef ﬁ cacy Of Psychoeducation Neuropsychiatric

Norio Sugawara, A. Fujii, Koji Tsuruga, 2019 .

attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Norio Sugawara, Kazutoshi Kubo, Masamichi Ishioka, 2019 .

attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Norio Sugawara, Kazutoshi Kubo, Masamichi Ishioka, 2019 .

Relationship between occupational stress and depression among psychiatric nurses in Japan

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2016, Archives of environmental & occupational health.

No association between bone mass and prolactin levels among patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2011, Human psychopharmacology.

Items of the Montgomery-Åsberg Depression Rating Scale Associated With Response to Paroxetine Treatment in Patients With Major Depressive Disorder

N. Yasui-Furukori, Kazuhiko Nakamura, S. Kaneko, 2016, Clinical neuropharmacology.

The influence of personality factors on paroxetine response time in patients with major depression.

N. Yasui-Furukori, S. Kaneko, A. Kaneda, 2011, Journal of affective disorders.